The psychedelic start-up Mindstate Design Labs, announced the company received approval from the U.S. Food and Drug Administration and the European Medicine Agency to begin human clinical trials studying the compound 5-MeO-MiPT.

Psychonauts call 5-MeO-MiPT “moxy.” Mindstate chose to develop the substance because 5-MeO-MiPT is “a psychedelic tofu,” according to DiNardo: Just as tofu takes on the flavors of any dish it’s put in, the drug takes on the properties of the other drugs with which it’s administered.